Literature DB >> 32015062

Pharmacogenomics: An evolving clinical tool for precision medicine.

Jennifer K Hockings1, Amy L Pasternak2, Angelika L Erwin3, Neil T Mason4, Charis Eng5, J Kevin Hicks6.   

Abstract

Pharmacogenomics, ie, the study of how an individual's genomic profile influences his or her response to drugs, has emerged as a clinical tool to optimize drug therapy. Certain variants in some genes increase the risk of severe, life-threatening adverse effects from certain drugs. Integrating pharmacogenomics into clinical practice to assist in drug selection and dosing has the potential to improve the outcomes of treatment, reduce the risk of drug-induced morbidity and death, and be cost-effective.
Copyright © 2020 The Cleveland Clinic Foundation. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32015062     DOI： 10.3949/ccjm.87a.19073

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  11 in total

1.  Pharmacogenomics meets precision cardio-oncology: is there synergistic potential?

Authors:  Jennifer K Hockings; Jessica A Castrillon; Feixiong Cheng
Journal:  Hum Mol Genet       Date:  2020-10-20       Impact factor: 6.150

Review 2.  Pharmacogenomics of drug transporters for antiretroviral long-acting pre-exposure prophylaxis for HIV.

Authors:  Nomusa M Zondo; Parveen Sobia; Aida Sivro; Sinaye Ngcapu; Veron Ramsuran; Derseree Archary
Journal:  Front Genet       Date:  2022-09-29       Impact factor: 4.772

Review 3.  Precision medicine journey through omics approach.

Authors:  Mandana Hasanzad; Negar Sarhangi; Sima Ehsani Chimeh; Nayereh Ayati; Monireh Afzali; Fatemeh Khatami; Shekoufeh Nikfar; Hamid Reza Aghaei Meybodi
Journal:  J Diabetes Metab Disord       Date:  2021-11-24

4.  PharmaKoVariome database for supporting genetic testing.

Authors:  Jungeun Kim; Jae-Pil Choi; Min Sun Kim; Jong Bhak
Journal:  Database (Oxford)       Date:  2022-10-18       Impact factor: 4.462

5.  Prevalence of pharmacogenomic variants in 100 pharmacogenes among Southeast Asian populations under the collaboration of the Southeast Asian Pharmacogenomics Research Network (SEAPharm).

Authors:  Chakkaphan Runcharoen; Koya Fukunaga; Insee Sensorn; Nareenart Iemwimangsa; Sommon Klumsathian; Hang Tong; Nam Sy Vo; Ly Le; Tin Maung Hlaing; Myo Thant; Shamsul Mohd Zain; Zahurin Mohamed; Yuh-Fen Pung; Francis Capule; Jose Nevado; Catherine Lynn Silao; Zeina N Al-Mahayri; Bassam R Ali; Rika Yuliwulandari; Kinasih Prayuni; Hilyatuz Zahroh; Dzul Azri Mohamed Noor; Phonepadith Xangsayarath; Dalouny Xayavong; Sengchanh Kounnavong; Somphou Sayasone; Zoe Kordou; Ioannis Liopetas; Athina Tsikrika; Evangelia-Eirini Tsermpini; Maria Koromina; Christina Mitropoulou; George P Patrinos; Aumpika Kesornsit; Angkana Charoenyingwattana; Sukanya Wattanapokayakit; Surakameth Mahasirimongkol; Taisei Mushiroda; Wasun Chantratita
Journal:  Hum Genome Var       Date:  2021-02-04

Review 6.  Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs.

Authors:  Osama A Badary
Journal:  Pharmacogenomics J       Date:  2021-02-04       Impact factor: 3.550

7.  Effect Modification by Social Determinants of Pharmacogenetic Medication Interactions on 90-Day Hospital Readmissions within an Integrated U.S. Healthcare System.

Authors:  Loren Saulsberry; Lavisha Singh; Jaclyn Pruitt; Christopher Ward; Dyson T Wake; Robert D Gibbons; David O Meltzer; Peter H O'Donnell; Wanda Cruz-Knight; Peter J Hulick; Henry M Dunnenberger; Sean P David
Journal:  J Pers Med       Date:  2022-07-15

8.  A retrospective analysis of actionable pharmacogenetic/genomic biomarker language in FDA labels.

Authors:  Shinji Yamazaki
Journal:  Clin Transl Sci       Date:  2021-04-09       Impact factor: 4.689

9.  Applicability of Pharmacogenomically Guided Medication Treatment during Hospitalization of At-Risk Minority Patients.

Authors:  Loren Saulsberry; Keith Danahey; Merisa Middlestadt; Kevin J O'Leary; Edith A Nutescu; Thomas Chen; James C Lee; Gregory W Ruhnke; David George; Larry House; Xander M R van Wijk; Kiang-Teck J Yeo; Anish Choksi; Seth W Hartman; Randall W Knoebel; Paula N Friedman; Luke V Rasmussen; Mark J Ratain; Minoli A Perera; David O Meltzer; Peter H O'Donnell
Journal:  J Pers Med       Date:  2021-12-10

10.  Strategies to Integrate Genomic Medicine into Clinical Care: Evidence from the IGNITE Network.

Authors:  Nina R Sperber; Olivia M Dong; Megan C Roberts; Paul Dexter; Amanda R Elsey; Geoffrey S Ginsburg; Carol R Horowitz; Julie A Johnson; Kenneth D Levy; Henry Ong; Josh F Peterson; Toni I Pollin; Tejinder Rakhra-Burris; Michelle A Ramos; Todd Skaar; Lori A Orlando
Journal:  J Pers Med       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.